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Abstract
Background: The increased demand for nephrology care for patients with chronic kidney disease (CKD)
necessitates a critical review of the need for secondary care facilities and the possibilities for referral back to primary
care. This study aimed to evaluate the characteristics and numbers of patients who could potentially be referred
back to primary care, using predefined criteria developed by nephrologists and general practitioners.
Method: We organised a consensus meeting with eight nephrologists and two general practitioners to define the
back referral (BR) criteria, and performed a retrospective cohort study reviewing records from patients under
nephrologist care in three hospitals.
Results: We reached a consensus about the BR criteria. Overall, 78 of the 300 patients (26%) in the outpatient
clinics met the BR criteria. The characteristics of the patients who met the BR criteria were: 56.4% male, a median
age of 70, an average of 3.0 outpatients visits per year, and a mean estimated glomerular filtration rate of 46 ml/
min/1,73m2. Hypertension was present in 67.9% of this group, while 27.3% had diabetes and 16.9% had cancer. The
patients who could be referred back represented all CKD stages except stage G5. The most common stage (16%)
was G3bA2 (eGFR 30 ≤ 44 and ACR 3 ≤ 30).
Conclusion: A substantial proportion of patients were eligible for referral back to primary care. These patients often
have a comorbidity, such as hypertension or diabetes. Future research should focus on generalisability of the BR
criteria, the feasibility of actual implementation of the back referral, follow-up assessments of renal function and
patient satisfaction.
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Background
Most patients with chronic kidney disease (CKD) have a
mild to moderate CKD (stages 1–3), as classified accord-
ing to the Kidney Outcomes Quality Initiative guidelines
[1, 2]. Consequently, most patients with CKD can be
treated by their general practitioner (GP). The Dutch
CKD guideline for primary care [3], comparable to the
National Institute for Health and Care Excellence guide-
lines in the UK [4], provides GPs with tools for diagnos-
tics, monitoring and treatment. Also, this guideline
clearly defines the criteria for consultation with, or refer-
ral to, secondary care providers; for instance, in the case
of a rapid decline in the glomerular filtration rate or se-
vere proteinuria, the GP should refer the patient to, or
at least consult, a nephrologist. Timely referrals have
been repeatedly shown to affect outcome measures, such
as mortality and reaching end-stage renal failure [5], and
are essential when a requirement for renal replacement
therapy is indicated.
The rising prevalence and incidence of CKD will in-
crease the number of referrals made to nephrology prac-
titioners [6–8], increasing healthcare costs and posing a
burden for both patients and nephrologists [9, 10]. How-
ever, it is questionable whether many of the referred pa-
tients with CKD actually need long-term care from a
nephrologist. Patients with stable CKD could be referred
back to primary care with the proper support [4]. The
increased demand for hospital care necessitates a period-
ical, broadly supported, criteria-based critical review of
patients in secondary care facilities, together with an
evaluation of the possibilities for referral back to primary
care where possible.
Remarkably, none of the above-mentioned guidelines
clearly indicate when patients can or should be referred
back to primary care, nor, to the best of our knowledge,
have any studies investigated the proportion and charac-
teristics of patients who might be eligible. The aim of
this study was therefore to develop criteria for referral
from secondary care back to primary care, and to evalu-
ate the characteristics and the number of patients who
could be eligible for back referral.
Materials and methods
Development of criteria for referral back to primary care
To define the back referral criteria (BR criteria) for dis-
charging patients with CKD to primary care, we orga-
nised a consensus meeting with eight nephrologists from
different hospitals in the south-east of the Netherlands
and two GPs, both members of the national CKD guide-
line committee (see names and hospitals or practices in
acknowledgements and author contributions). In this
meeting, we also defined which patients could not be re-
ferred back to primary care. A summary of the meeting
was circulated among the participants for feedback, and
a consensus document was made. The BR criteria were
returned to all participants for checking, and were ac-
cepted by all.
Proportion and characteristics of patients who fulfilled
the BR criteria
Study setting
In a retrospective cohort study, we reviewed the records
of patients under nephrologist care in three hospitals
(VieCurie Medical Center (VMC) in Venlo, and Canisius
Wilhelmina Hospital (CWH) and Radboud university
medical center (RUMC) in Nijmegen). We recruited par-
ticipants at the outpatient clinics because hospitalized
patients are by definition not stable. Patients were in-
cluded for their kidney disease, regardless of the aeti-
ology. Also, patients requiring follow-up after
hospitalization, patients with a history of acute kidney
injury or previous kidney transplantation were included.
Patients visiting the renal clinics were informed about
the study, and their informed consent was obtained prior
to their participation. There were no exclusion criteria.
Patients were recruited by all nephrologists in the par-
ticipating renal clinics. The recruitment period lasted
until about 100 patients per clinic were included. This
study is an exploration of back referral criteria and the
number of potential patients eligible for referral back.
For this, the patients were not actually referred back to
primary care.
Data collection and analysis
The researchers (CvD, resident in general practice and
PhD candidate in CKD in primary care, and DvD, resi-
dent in internal medicine) extracted the patient demo-
graphics and clinical data from the medical records. The
authorised web-based system Castor was used for data
collection and storage. This system enables researchers
to build electronic Case Report Forms and store data
[11]. The researchers completed a standard form for
each patient, then checked whether the patient met the
BR criteria. A patient’s nephrologist was consulted by
the researchers in the following cases: doubts about the
back referral; a lack of clarity in the patient’s medical
file; if the CKD was stable but was caused by a specific
nephrological disease; and when the researchers found
notes about a back referral in the medical file despite the
patient not meeting the BR criteria. We used descriptive
statistics (SPSS version 25) to assess the patients’ charac-
teristics and the proportion of patients with CKD who
could be referred back to primary care. We used chi-
square tests and independent-sample t-tests to assess the
statistical significance of the results. In the case of non-
normal distributions, we used Mann Whitney U-tests to
evaluate statistical significance. A P-value < 0.05 was
considered significant.
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Results
The following BR criteria were defined:
 Patients with stable kidney function AND stable
blood pressure AND stable metabolic parameters, in
whom renal replacement therapy is not expected
within five years (for definitions, see textbox).
 Patients with haematuria and/or proteinuria less
than 1 g/24 h AND with stable kidney function
AND stable blood pressure. Exception: patients with
IgA nephropathy who are eligible (now or in the
future) for immunosuppressive therapy.
 Patients not eligible for renal replacement therapy
(because of comorbidity, age or patient preference),
provided that the patient’s kidney function and
metabolic parameters are stable.
Stable kidney function: a decrease in estimated glomerular filtration rate
(eGFR) less than
1a) 25% compared to the first measurement within five years OR 1b) 5
ml/min/1.73 m2/year
AND
2) proteinuria less than 0.5 g in a 24-h urine collection in case of glom-
erular haematuria and less than 1 g per 24 h in the absence of
haematuria.
Stable blood pressure: patients with a stable blood pressure at or below
their individual target value and without drug adjustments in the last
two consultations.
Stable metabolic parameters: patients without medication changes
concerning phosphate, calcium, parathormone or haemoglobin in the
last two consultations.
In addition, we defined the criteria for patients who
should not be referred back to primary care:
 Patients with a rapid decrease of kidney function,
defined as a drop in eGFR of more than 5 ml/min/
1.73m2/year OR a decrease of more than 25% in five
years.
 Patients with proteinuria of more than 1 g/24 h.
 Patients with an eGFR less than 30 ml/min/1.73m2,
showing progression and with reasonable to good
physical health, who would be eligible for renal
replacement therapy.
 Patients expected to require renal replacement
therapy within five years.
 Patients using immune suppressive drugs in the
context of a renal disease or after a kidney
transplant.
 Patients with specific nephrological diseases with a
risk of relapse or a high risk of disease progression,
such as patients with polycystic kidney disease or
patients with lupus nephritis. Referral back to
primary care is only considered possible in patients
with stable kidney disease, five years after stopping
immunosuppressive therapy.
 Patients with multimorbidity and/or metabolic
complications which cannot be regulated in primary
care and/or for which medication shifts have
occurred within the last two consultations.
 Patients with CKD not amenable to palliative
therapy in primary care due to difficulties in
symptom regulation.
Study population and patients fulfilling the BR criteria
The study was conducted between February and
September 2018. We included a total of 300 patients:
102 patients from CWH, 100 patients from VMC and 98
patients from RUMC. Of those, 57.5% were male, the
median age was 67.5 years and the average number of
outpatient visits was 3.8 times a year. The average eGFR
was 42ml/min/1.73m2, and most patients had moderate
(40.9%) to severe (43.2%) albuminuria. Hypertension
(60%), diabetes mellitus (24.7%) and cancer (unspecified)
(19.7%) were the most common comorbidities.
Glomerular pathology was the most common aetiology
for CKD (see Table 1).
Overall, 78 of the 300 patients (26%) in the outpatient
clinics met the BR criteria (see Fig. 1), varying between
23 and 30% per clinic. Of the patients who met the BR
criteria, 56.4% were male, and their median age was 70
years (see Table 1). Their average monitoring frequency
was lower (3.0 vs. 4.1 times per year, P = 0.000) and
their mean eGFR was higher (46 vs. 40 ml/min/1.73m2,
P = 0.044) than the patients who did not meet the BR
criteria. Patients who met the BR criteria more often had
heart failure (19.2% vs. 7.8%, P = 0.007) and had suffered
a transient ischaemic accident (TIA) or a
cerebrovascular accident (CVA) (21.8% vs. 10.8%, P =
0.018), but less commonly had cancer (16.9% vs. 20.8%,
P = 0.042). Patients eligible for referral back to primary
care were classified into all CKD stages, most commonly
into stages G3bA2 (16%) and G4A2 (14.1%) (see
Table 2).
Discussion
Summary of the main findings
When applying the BR criteria to the records of patients
at the renal clinics, the proportion of patients with CKD
who could be referred back to primary care varied
between 23 and 30% per clinic. In addition, several
patients seemed to be potential candidates for a future
back referral, such as patients with stable CKD but who
currently had too short of a follow-up period, or patients
who had recently changed their blood pressure medica-
tion because of side effects rather than problems
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Table 1 Characteristics of all patients in the renal clinics, and a comparison between those who were and were not considered
eligible for referral back (BR) to primary care.
All patients
N = 300
Patients meeting the BR
criteria
N = 78 (26%)
Patients not meeting BR
criteria
N = 222 (74%)
P-
value
Number of patients per hospital CWH: 102/300
(34.0%)
CWH: 31/102 (30.4%) CWH: 71/102 (69.6%)
VMC: 100/300 (33.3%) VMC: 23/100 (23.0%) VMC: 77/100 (77.0%)
RUMC: 98/300
(32.7%)
RUMC: 24/98 (24.5%) RUMC:74/98 (75.5%)
Demographics patients
Gender, male (%) 173 (57.5%) 44 (56.4%) 129 (58.1%) 0.794
Age in years, median (range) 67.5 (19–96) 70 (25–88) 67 (19–96) 0.265








ADPKD* 33/300 (11.0%) 7/78 (9.0%) 26/222 (11.7%) 0.506
Glomerular diseases1 82/300 (27.3%) 18/78 (23.1%) 64/222 (28.8%) 0.327
Systemic diseases2 20/300 (6.7%) 0/78 (0.0%) 20/222 (9.0%) 0.006
Tubulointerstitial nephritis 11/300 (3.7%) 2/78 (2.6%) 9/222 (4.1%) 0.547
Drug-induced CKD 7/300 (2.3%) 2/78 (2.6%) 5/222 (2.3%) 0.875
Vascular CKD 61/300 (20.3%) 19/78 (24.4%) 42/222 (18.9%) 0.304
Diabetic nephropathy 26/300 (8.7%) 8/78 (10.3%) 18/222 (8.1%) 0.562
Other cause3 38/300 (12.7%) 11/78 (14.1%) 27/222 (12.2%) 0.658
Unknown cause 20/300 (6.7%) 11/78 (14.1%) 9/222 (4.1%) 0.002
Measurements
eGFR (ml/min/1.732), mean 42 ± 21.07 46 ± 19.95 40 ± 21.3 0.044
Stage proteinuria, (%) 0.007
A1 47/296 (15.9%) 15/78 (19.2%) 32/218 (14.7%)
A2 121/296 (40.9%) 41/78 (52.6%) 80/218 (36.7%)
A3 128/296 (43.2%) 22/78 (28.2%) 106/218 (48.6%)




































Angina pectoris 33/271 (12.2%) 10/77 (13.0%) 23/194 (11.9%) 0.797
Myocardial infarction 42/272 (15.4%) 16/78 (19.8%) 26/194 (13.4%) 0.142
Heart failure 30 /270 (11.1%) 15/78 (19.2%) 15/192 (7.8%) 0.007
Hypertension (K86.87) 180/274 (65.7%) 53/78 (67.9%) 127/196 (64.8%) 0.620
TIA or CVA 38/272 (14.0%) 17/78 (21.8%) 21/194 (10.8%) 0.018
Hemiplegia 0/271 (0%) 0/78 (0%) 0/193 (0%) NA
Peripheral vascular disease 41/270 (15.2%) 9/77 (11.5%) 32/193 (16.6%) 0.312
Diabetes mellitus 74/270 (27.4%) 21/77 (27.3%) 53/193 (27.5%) 0.608
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reaching their target values. The criteria were easily ap-
plicable and their use required little discussion. In only
four cases, the judgments of the researchers and ne-
phrologists overruled the BR criteria (for more detail see
Fig. 1). Patients eligible for referral back to primary care
represented all CKD stages except for stage G5, and did
not differ much from the patients not eligible for back
referral in terms of their demographics..
Prerequisites for implementation in practice
A number of conditions must be met before patients can
be referred back to primary care. First of all, the quality
of care (QoC) for patients with CKD in primary care
must be guaranteed. Some studies indicated that the
QoC for these patients received solely from a GP is
suboptimal [12, 13], while others have shown that GPs
deliver an appropriate quality of care for patients
referred back to primary care, in terms of periodic renal
monitoring, preventing the deterioration of kidney
function and maintaining blood pressure within an
appropriate range [14, 15]. GPs recognition of patients
with CKD in primary care and receiving co-management
assistance from nephrologists, are both factors associated
with improved QoC [13]. Our previous study shows that
not all patients indicated for nephrologist care, actually
receive nephrologist consultation or co-management. In
addition, for patients aged 80 and older, it was question-
able whether management by nephrologists contributes
to a better clinical outcome [16]. To enhance the QoC
in primary care, we believe it would be helpful to embed
CKD care within the care of other chronic conditions to
guarantee a periodic follow up [17]. Furthermore, to
overcome other doubts about QoC in the primary care
setting, we recommend the provision of care according
Table 1 Characteristics of all patients in the renal clinics, and a comparison between those who were and were not considered
eligible for referral back (BR) to primary care. (Continued)
All patients
N = 300
Patients meeting the BR
criteria
N = 78 (26%)
Patients not meeting BR
criteria
N = 222 (74%)
P-
value
Uncomplicated 35/270 (13.0%) 8/77 (10.4%) 27/193 (14.0%)
Complicated 39/270 (14.4%) 13/77 (16.9%) 26/193 (13.5%)
COPD 20/272 (7.4%) 6/78 (7.7%) 14/194 (7.2%) 0.892
Dementia 0/272 (0%) 0/78 (0%) 0/194 (0%) NA
Liver disease 6/270(2.3%) 0/78 (0%) 6/192 (3.1%) 0.288
Mild 5/270 (1.9%) 0/78 (0%) 5/192 (2.6%)
Moderate / severe 1/270 (0.4%) 0/78 (0%) 1/192 (0.5%)
HIV or AIDS 1/271 (0.3%) 0/77 (0%) 1/194 (0.5%) 0.528
Cancer 53/269 (19.7%) 13/77 (16.9%) 40/192 (20.8%) 0.042
Solid tumour 51/269 (19%) 11/77 (14.3%) 40/192 (20.8%)
Metastatic 2/269 (0.7%) 2/77 (2.6%) 0/192 (0%)
Haematological malignancy 4/269 (1.5%) 0/78 (0%) 4/191 (2.1%) 0.198
Connective tissue disease 21/273 (7.7%) 4/77 (5.2%) 17/196 (8.7%) 0.332
Peptic ulcer 6/271 (2.2%) 2/77 (2.6%) 4/194 (2.1%) 0.787










Angiotensin receptor blockers 186/272 (68.4%) 50/78 (64.1%) 136/194 (70.1%) 0.336
Diuretics 92/269 (34.2%) 25/76 (32.9%) 67/193 (34.7%) 0.777
Beta blockers 130/272 (47.8%) 38/78 (48.7%) 92/194 (47.4%) 0.847
Calcium channel blockers 105/272 (38.6%) 25/78 (32.1%) 80/194 (41.2%) 0.159
Vitamin D / alfacalcidol 151/271 (55.7%) 39/78 (50.0%) 112/193 (58.0%) 0.228
Erythropoeitin 19/272 (6.3%) 4/78 (5.1%) 15/194 (7.7%) 0.446
Phosphate binders 10/272 (3.7%) 0/78 (0%) 10/194 (5.2%) 0.041
Immunosuppressive drugs 67/300 (22.3%) 0/78 (0%) 67/222 (30.2%) < 0.001
1 Glomerular diseases include: glomerulonephritis, nephrotic syndrome (any cause), glomerular proteinuria or haematuria (without biopsy), IgA nephropathy
2 Systemic diseases include: systemic lupus erythematosus, vasculitis, sarcoidosis
3 Other causes include: postrenal cause, renal artery stenosis, cancer (treatment)
± = standard deviation
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to a shared care model. The co-management of patient
care by nephrologists and GPs led to the increased
monitoring of eGFR, urine albumin and metabolic pa-
rameters, and resulted in more prescriptions of
angiotensin-converting enzyme inhibitors and angio-
tensin receptor blockers [18]. Shared care models for
chronic conditions are predominantly found to have a
positive effect [19–21]. Combining shared care with
information technology such as a pop-up in medical
records for recognising CKD, decision support in
medical records or a web-based consultation system
could also enhance QoC [22, 23].
Second, for the interdisciplinary management of
patients, it is essential to make agreements on the tasks,
responsibilities and communication between GPs and
nephrologists. Not all professionals in the field will have
the same expectations, as even among nephrologists
there are different views about various tasks [24];
therefore, agreements should preferably be made
regionally to ensure the close communication of GPs
and nephrologists and to make use of a pre-existing col-
laborative relationships. A shared clinical information
system could also facilitate better communication be-
tween primary and secondary care [25]. The current
Fig. 1 Algorithm of patients selected for referral back (BR) to primary care. The patients not meeting the BR criteria are removed on the right-
hand side. *Exceptions: - In one case, the nephrologists were worried about the risk of renal decline after an episode of acute kidney injury,
despite the patient’s CKD stability, and advised the continued follow up of this patient at the renal clinic. - Three patients did not strictly meet
the BR criteria, but were still eligible for referral back; two patients had more severe proteinuria, which was stable for over five years, while one
patient had recently started blood pressure medication, but the low complexity of their case allowed their referral back to primary care
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literature reveals that both GPs and nephrologists prefer
shared care [26, 27], but only when sufficient informa-
tion exchange is provided [24, 28]. GPs have said that,
besides conservative care for older and frail patients with
advanced CKD, they have little experience in treating pa-
tients with advanced CKD and welcome guidance from
nephrologists [29]. Several studies have already been ex-
ecuted to improve co-ordination between primary and
secondary care; for example, researchers introduced a
kidney failure risk equation, which is a predictive model
to determine whether care by a nephrologist is required,
based on the patient’s risk for kidney failure [30, 31]. A
predictive model alone is not sufficient for the co-
ordination of CKD care between primary and secondary
practices, however our BR criteria could also contribute
to personalised decision making.
Last but not least, it is important to know whether
patients are willing to be referred back to primary
care. Not much has been written about this, despite
patient willingness being a prerequisite for back
referral. One study found that patients prefer to
receive care from their GP, provided that GPs have
access to a specialist for consultation or a system in
which diagnostic procedures are organised by a
specialist with patients subsequently being referred
back to the GP for care [26]. Patients views and
experiences concerning CKD care still need to be
explored in more detail.
Advice for further research
Future research should focus on the actual
implementation of the referral of patients with CKD
back to primary care. The enabling and disabling factors
need to be further explored, taking into account the
opinions of patients, GPs and nephrologists. We didn’t
study the underlying motives for push and pull factors
among GPs and specialists. This also would require
additional qualitative research. Further studies on
supportive measures, such as ICT and health apps, are
needed. In addition, it is very important to investigate
the sustainability of back referrals and intervene on
aspects that deviate from the intentions of the initial
criteria. This could lead to changes in criteria or to extra
interventions that support the referral back to primary
care. Some stakeholders may ask for studies on the
(cost-) effectiveness of back referrals.
Strengths and limitations
To our knowledge, this is the first study in which the
criteria for back referrals for patients with CKD have
been explicitly formulated. We decided to take a
regional approach by inviting eight nephrologists from
different hospitals (general and academic) and two GPs,
all from the southeast of the Netherlands, to identify the
criteria for back referrals. This interdisciplinary
approach was intended to ensure that these criteria
resulted in a longer-lasting working relationship to
Table 2 Patients eligible for referral back to primary care, classified by stage.
Different colours denote different levels of risk for cardiovascular events, progression to end-stage renal failure and mortality: green: low risk; yellow: moderately
increased risk; orange: high risk; red, very high risk Classification according to the Kidney Outcomes Quality Initiative guidelines (KDOQI).
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provide the trust needed for a nephrologist to refer a pa-
tient back to primary care. The consensus process could
have involved more than two GPs, but as the referral
back should be initiated by nephrologists, we considered
this to be an adequate balance. In addition, the recently
developed transmural guideline supported the consensus
process [32]. Other potential limitations exist in this
work. We only reviewed the records of patients under
nephrologist care, but patients with CKD who are
treated by a general internist would likely also meet the
BR criteria and could be included in future studies. We
tried to avoid selection bias by instructing the nephrolo-
gists to invite all patients to participate in this study;
nevertheless, we cannot fully exclude the possibility that
selection bias may have occurred.
Conclusion
Taking the starting point that patients with less-
progressive moderate or even stable advanced CKD can
be managed in primary care, we developed criteria for
back referrals. When applying these BR criteria to pa-
tients with CKD in outpatient clinics, a substantial pro-
portion of patients turned out to be eligible for referral
back to primary care. These patients often had cardio-
vascular comorbidities, and their renal care could there-
fore constitute part of a chronic care programme
managed by their GP. Given the nature of CKD, such a
programme would require a strong shared-care identity,
supported by consultations between GPs and nephrolo-
gists. Future research should focus on the feasibility of
actually implementing referrals back to primary care, the
follow up of renal function in such a setting, and patient
satisfaction with care.
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